|
C11ORF54 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.5295999995254E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.45730000026212E-07 |
| Normal-vs-Stage2 |
8.30240000000426E-05 |
| Normal-vs-Stage3 |
1.46500000020033E-07 |
| Normal-vs-Stage4 |
2.5704999995213E-07 |
| Stage1-vs-Stage2 |
4.177600E-01 |
| Stage1-vs-Stage3 |
2.892200E-01 |
| Stage1-vs-Stage4 |
3.925000E-01 |
| Stage2-vs-Stage3 |
1.707400E-01 |
| Stage2-vs-Stage4 |
1.595980E-01 |
| Stage3-vs-Stage4 |
8.385400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.73589999947255E-07 |
| Normal-vs-AfricanAmerican |
1.6691000004343E-07 |
| Normal-vs-Asian |
1.174380E-02 |
| Caucasian-vs-AfricanAmerican |
5.474200E-02 |
| Caucasian-vs-Asian |
7.972600E-01 |
| AfricanAmerican-vs-Asian |
8.669000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.79229999969822E-07 |
| Normal-vs-Female |
1.38370000013488E-07 |
| Male-vs-Female |
2.614200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.72220000044443E-07 |
| Normal-vs-Extreme_Weight |
2.14209999960246E-07 |
| Normal-vs-Obese |
6.57469999998384E-07 |
| Normal-vs-Extreme_Obese |
5.623500E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.291000E-01 |
| Normal_Weight-vs-Obese |
6.572000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.564170E-01 |
| Extreme_Weight-vs-Obese |
3.709400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.342000E-02 |
| Obese-vs-Extreme_Obese |
2.338600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.37190000026877E-07 |
| Normal-vs-Age(41-60Yrs) |
7.40469999982452E-07 |
| Normal-vs-Age(61-80Yrs) |
3.04199999967558E-07 |
| Normal-vs-Age(81-100Yrs) |
7.433200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.505620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.880400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.251600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.928600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.466250E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.488170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.41009999957242E-07 |
| Normal-VS-Type2 PRCC |
4.094500000007E-05 |
| Normal-VS-KIRP CIMP |
1.19340004545165E-09 |
| Normal-VS-Unclassified PRCC |
3.41220000033005E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.596900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.08800000120368E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
7.770000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.0844003472954E-10 |
| Type2 PRCC-VS-Unclassified PRCC |
1.359580E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.61200000015072E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02819999999271E-05 |
| Normal-vs-N1 |
1.03500000014911E-07 |
| Normal-vs-N2 |
2.01670000032905E-07 |
| N0-vs-N1 |
4.090400E-02 |
| N0-vs-N2 |
1.502380E-01 |
| N1-vs-N2 |
8.027700E-02 |
|
|
